1. Home
  2. FOLD vs BBAR Comparison

FOLD vs BBAR Comparison

Compare FOLD & BBAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Amicus Therapeutics Inc.

FOLD

Amicus Therapeutics Inc.

HOLD

Current Price

$14.36

Market Cap

4.4B

Sector

Health Care

ML Signal

HOLD

BBAR

Banco BBVA Argentina S.A. ADS

HOLD

Current Price

$17.66

Market Cap

3.7B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
FOLD
BBAR
Founded
2002
1886
Country
United States
Argentina
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Commercial Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
4.4B
3.7B
IPO Year
2007
N/A

Fundamental Metrics

Financial Performance
Metric
FOLD
BBAR
Price
$14.36
$17.66
Analyst Decision
Buy
Strong Buy
Analyst Count
9
1
Target Price
$27.56
$17.00
AVG Volume (30 Days)
21.4M
560.4K
Earning Date
02-18-2026
03-04-2026
Dividend Yield
N/A
0.79%
EPS Growth
N/A
N/A
EPS
N/A
0.21
Revenue
$598,704,000.00
$1,535,146,865.00
Revenue This Year
$21.49
$0.64
Revenue Next Year
$18.46
$15.77
P/E Ratio
N/A
$30.31
Revenue Growth
21.28
N/A
52 Week Low
$5.51
$7.76
52 Week High
$14.36
$23.90

Technical Indicators

Market Signals
Indicator
FOLD
BBAR
Relative Strength Index (RSI) 89.94 50.00
Support Level $14.26 $16.96
Resistance Level $14.35 $19.20
Average True Range (ATR) 0.05 0.80
MACD -0.12 -0.13
Stochastic Oscillator 100.00 29.46

Price Performance

Historical Comparison
FOLD
BBAR

About FOLD Amicus Therapeutics Inc.

Amicus Therapeutics Inc is a patient-dedicated biotechnology company focused on discovering, developing and delivering novel high-quality medicines for people living with rare diseases. With extraordinary patient focus, the company is committed to advancing and expanding a pipeline of cutting-edge medicines for rare diseases. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The company has one segment focused on the discovery, development, and commercialization of therapies to treat a range of devastating rare and orphan diseases.

About BBAR Banco BBVA Argentina S.A. ADS

Banco BBVA Argentina SA is a banking services provider in Argentina. It provides financial assistance to large corporations, small and medium-sized companies, as well as individuals. It bank provides services through retail, corporate, investment banking, and Small and medium-sized companies divisions. Through the retail banking segment, it provides banking products and services to individuals, corporate banking deals with services to corporates, and the small and medium-sized companies segment focuses on foreign trade, agricultural business, and digital products.

Share on Social Networks: